Evidence map›Paper›PMID 42605313›Full record

ArticleCanadian journal of kidney health and disease2026

Prognostic Performance of Ellipsoid Kidney Volume Measurement in a Computed Tomography-Heavy ADPKD Cohort: A Retrospective Observational Cohort Study.

Marwan Abdrabou, Ayub Akbari, Wael Shabana, Mohan Biyani, Gregory L Hundemer, Manish M Sood, Arlene B Chapman, Deena Fremont, Pierre Antoine Brown

Abstract read
In one paragraph

Article in Canadian journal of kidney health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marwan AbdrabouFaculty of Medicine, University of Ottawa, Ottawa, ON Canada.
Ayub AkbariDivision of Nephrology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
Wael ShabanaDivision of Radiology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
Mohan BiyaniDivision of Nephrology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
Gregory L HundemerInflammation and Chronic Disease Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada.ORCID https://orcid.org/0000-0003-3559-3531
Manish M SoodInflammation and Chronic Disease Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Arlene B ChapmanDepartment of Medicine, The University of Chicago, Illinois, Chicago, USA.
Deena FremontInflammation and Chronic Disease Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada.ORCID https://orcid.org/0009-0006-8670-2813
Pierre Antoine BrownInflammation and Chronic Disease Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada.ORCID https://orcid.org/0000-0002-0283-4530

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Accurate prognostic classification in autosomal dominant polycystic kidney disease is important for risk stratification and treatment decisions, including tolvaptan eligibility. Although the ellipsoid method has shown good performance for kidney volume measurement in magnetic resonance imaging cohorts, data from cohorts imaged predominantly with computed tomography remains limited. Objective: To evaluate the agreement between the ellipsoid and manual segmentation methods for kidney volume measurement in a computed tomography-heavy cohort of patients with autosomal dominant polycystic kidney disease, with a focus on prognostic classification and identification of high-risk disease. Design: Retrospective observational cohort study. Setting: The Ottawa Hospital Cystic Kidney Disease Clinic, a tertiary academic center in Ottawa, Ontario, Canada. Patients: One hundred fifty-one patients with autosomal dominant polycystic kidney disease who underwent cross-sectional abdominal imaging suitable for volumetric assessment between January 2018 and February 2022, including 107 computed tomography studies and 44 magnetic resonance imaging studies. Measurements: Height-adjusted total kidney volume, Mayo Clinic Imaging Classification, and classification of high-risk disease (classes 1C-1E). Methods: Height-adjusted total kidney volume was measured using both manual segmentation, the reference standard, and the ellipsoid method. Agreement in kidney volume measurement was assessed using intraclass correlation coefficients, Bland-Altman analysis, and mean percent difference. Agreement in Mayo Clinic Imaging Classification was assessed using weighted Cohen kappa. Diagnostic performance of the ellipsoid method for identifying high-risk disease was evaluated using sensitivity, specificity, positive predictive value, and McNemar testing. Results: The ellipsoid method showed good concordance with manual segmentation height-adjusted total kidney volume measurement, with an intraclass correlation coefficient of 0.93 overall, 0.92 in the computed tomography subgroup, and 0.96 in the magnetic resonance imaging subgroup. The ellipsoid method underestimated kidney volume by a mean of 12.7%. Agreement in Mayo Clinic Imaging Classification was high, with a weighted Cohen kappa of 0.87, although 25.8% of cases were misclassified, most often to a lower risk class. For identification of high-risk disease, the ellipsoid method had a sensitivity of 83.0% and a specificity of 98.0% overall; in the computed tomography subgroup, sensitivity was 85.5% and specificity was 97.4%. Limitations: Single-center design, use of a single reader, and cross-sectional analysis without longitudinal follow-up. Discussion: In this computed tomography-heavy cohort, the ellipsoid method showed good concordance with manual segmentation for kidney volume measurement and high specificity for identifying high-risk disease. However, systematic underestimation may lead to downward misclassification, particularly in borderline cases.

Indexed as

computed tomographyellipsoid methodkidney volume

Identifiers

PMID42605313
PMCPMC13477545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.